Download
HTML Embed
HTML EMBED
Click to Copy

Latest Episodes

Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace
Sign up for "Econ Extra Credit with David Brancaccio" Here

The Trump administration wants drug companies to lower prices. This is what’s actually happening.

by Dan Gorenstein Jul 5, 2018
Pfizer recently raised the list prices for more than 40 of its prescription medications, including the pain med Lyrica. It’s the second time this year Pfizer has boosted list prices. The increases come at a time of increased public and…

Botox is a multi-billion dollar, potentially deadly monopoly

by Kai Ryssdal, Emily Henderson, and Sean McHenry Oct 31, 2017
The product comes from a substance so lethal that it could be used as a potential agent of bioterrorism.
Andreas Rentz/Getty Images

Why pharma companies are bowing out of generics

by Dan Gorenstein Aug 2, 2017
Many generic drugs have become so cheap, they have pencil-thin profit margins.
KAREN BLEIER/AFP/Getty Images